Optimizing Outcomes Across the Pharma Value Chain Network featuring Axendia

The ability of bio-pharmaceutical manufacturers to deliver quality drug products during challenging market conditions is critical for ensuring sustainability over the long run. The COVID-19 pandemic underscored the need to transform the traditional bio-pharmaceutical supply chain to have greater agility and resiliency during market swings and periods of volatility.
 

Listen to this on-demand webinar as Pharmaceutical Outsourcing Editor-in-Chief Mike Auerbach has a lively discussion with industry experts Daniel Matlis, President and Founder, Axendia, and David Leitham, SVP and GM, Pharmaceutical Business Unit, AspenTech, as they address these hot-button topics:

  • What are the challenges that have limited the pharmaceutical industry from moving forward with digitalization?
  • What is digital maturity and why is it a requirement for pharmaceutical manufacturing?
  • Where should pharmaceutical companies begin their digitalization journey?

Learn more in this on-demand webinar.


Optimizing Outcomes Across the Pharma Value Chain Network featuring Axendia

Why we collect this data:

AspenTech is collecting and may process your personal data for a variety of reasons related to our business and our ability to deliver the best possible products, customer support service and overall user experience. Accordingly, we may use your personal data to administer research surveys, to accurately deliver contracted services, to register you for events, to understand your preferences and to detect and prevent any fraudulent or unauthorized activities. Please refer to AspenTech’s Privacy and Security Policy, which is available here, for more information regarding our collection and processing of your personal data.

Optimizing Outcomes Across the Pharma Value Chain Network featuring Axendia

Hello . If this is not you

Thank you for viewing this on-demand webinar

If you weren't redirected, click here